Author:
Antonini M. G.,Babudieri S.,Maida I.,Baiguera C.,Zanini B.,Fenu L.,Dettori G.,Manno D.,Mura M. S.,Carosi G.,Puoti M.
Publisher
Springer Science and Business Media LLC
Subject
Infectious Diseases,Microbiology (medical),General Medicine
Reference18 articles.
1. Strader DB, Wright T, Thomas DL and Seeff LB (2004). American Association for the Study of Liver Diseases: diagnosis, management, and treatment of hepatitis C. Hepatology 39: 1147–1171
2. Fried MW (2002). Side effects of therapy of hepatitis C and their management. Hepatology 36: S237–S244
3. Puoti M, Babudieri S, Rezza G, Viale P, Antonini MG, Maida I, Rossi S, Zanini B, Putzolu V, Fenu L, Baiguera C, Sassu S, Carosi G and Mura MS (2004). Use of pegylated interferons is associated with an increased incidence of infections during combination treatment of chronic hepatitis C: a side effect of pegylation?. Antivir Ther 9: 627–630
4. Soza A, Everhart JE, Ghany MG, Doo E, Heller T, Promrat K, Park Y, Liang TJ and Hoofnagle JH (2002). Neutropenia during combination therapy of interferon alfa and ribavirin for chronic hepatitis C. Hepatology 36: 1273–1279
5. Cooper CL, Al-Bedwawi S, Lee C and Garber G (2006). Rate of infectious complications during interferon-based therapy for hepatitis C is not related to neutropenia. Clin Infect Dis 42: 1674–1678
Cited by
45 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献